Company Profile
Logical Therapeutics, Inc. is a venture-backed, privately held biotechnology company focused on the development of products that treat diseases associated with inflammation.
Bio-activated Pro-drugs target large patient populations where currently available medicines exhibit undesirable side effects, creating significant opportunity for safer alternatives.
Our bio-activated NSAID prodrugs are new chemical entities that are designed to significantly reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. Our lead compound, LT-NS001, is a naproxen prodrug which has completed Phase 2b development..
The Company has established an extensive intellectual property portfolio across each of its therapeutic programs, which cover our molecules as well as our platforms.
Contact Us
124 Washington Street, Suite 101
Foxboro, MA 02035
781.290.0900 phone
781.290.0911 fax
info@logicaltx.com